Tuesday, 11 August 2020


FDA nod for Samsung's new radiography system

07 August 2015 | News | By BioSpectrum Bureau

FDA nod for Samsung's new radiography system

The GC85A is the latest expansion of Samsung's growing DR portfolio

The GC85A is the latest expansion of Samsung's growing DR portfolio

Singapore: NeuroLogica, a subsidiary of Samsung Electronics has announced that the Samsung GC85A Digital Radiography (DR) system has received 510(k) FDA clearance, paving the way for its availability in the US market. The GC85A is the latest expansion of Samsung's growing DR portfolio, which also includes the mobile digital GM60A, the U-arm digital GU60A, and the ceiling digital GC80.

Samsung's DR systems combine advanced imaging technology, award-winning design and user-friendly automated workflows to meet the demands of radiology departments. The Samsung GC85A is a ceiling digital X-ray system that offers streamlined workflows, diagnostic confidence and improved total cost of ownership. Other key features include, S-Vue imaging engine that provides dependable and accurate diagnoses in various conditions with reliably clear images, enhanced sharpness and clarity, and adjustable contrast presets, Wireless, lightweight S-Detector with high DQE and a portable grid which displays the patient's body structure clearly and easily without increasing dose.

The system also has Smart Control, that enables the operator to precisely position the entire system with one touch of the control panel's buttons. The user can move a motorized, tilting receptor with a remote control from -20 to 90 degrees to various areas such as skulls or hands with no need for a table.

"The Samsung GC85A represents NeuroLogica's latest commitment to introducing user and patient-centric innovation to healthcare to provide fast, easy and accurate diagnoses. The system's superior image quality and ease of control will enable users to experience a new level of efficiency with a DR system designed for streamlined operation," said Mr David Webster, vice-president of global sales and chief marketing officer at NeuroLogica.

 

 


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls